Glaucoma neovascular cortisónico: Reporte de caso

Abstract

Background: Corticosteroids neovascular glaucoma is a very rare disease as it is uncommon for the young-adult population to respond to an increase in intraocular pressure along with the development of glaucoma from prolonged use of topical corticosteroids. Its clinical presentation is usually in advanced stages, making early diagnosis complex and generally resulting in irreversible blindness. There are currently few studies that provide information on its etiology and prevalence. Therefore, it represents a challenge for diagnosis and timely treatment. Case Presentation: A thirty-one-year-old female patient presented with pain and decreased bilateral visual acuity. She indicated that she had been treated with corticosteroid eye drops, secondary to conjunctivitis, indefinitely for the past three years. She underwent multiple evaluations without an accurate diagnosis. Finally, she was diagnosed with neovascular glaucoma due to chronic use of corticosteroids in the right eye. Her treating physician proposed a trabeculectomy, with encouraging results in terms of remission of intraocular pressure for about two years and prevention of progression of her visual capacity. Conclusion: Corticosteroid-induced neovascular glaucoma is rare, and there is little literature addressing this pathology. Trabeculectomy is an encouraging alternative, and the prognosis is generally guarded.